Abstract
Histone deacetylases (HDACs) modify nucleosomal histones, have a key role in the regulation of gene transcription1,2, and may be involved in cell-cycle regulation, differentiation and human cancer3,4. Purified recombinant human HDAC1 protein was used to screen a cDNA expression library, and one of the clones identified encoded DNA topoisomerase II (Topo II), an enzyme known to have a role in transcriptional regulation and chromatin organization5,6. Coimmunoprecipitation experiments indicate that HDAC1 and HDAC2 are associated with Topo II in vivo under normal physiological conditions. Complexes containing Topo II possess HDAC activities, and complexes containing HDAC1 or HDAC2 possess Topo II activities. HDAC and Topo II modify each other's activity in vitro and in vivo. Our results indicate the existence of a functionally coupled complex between these two enzymes and offer insights into the potential mechanisms of action of both enzymes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Struhl, K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599–606 (1998).
Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349–352 (1997).
Kouzarides, T. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9, 40–48 (1999).
Cress, W.D. & Seto, E. Histone deacetylases, transcriptional control, and cancer. J. Cell Physiol. 184, 1–16 (2000).
Wang, J.C. DNA topoisomerases. Annu. Rev. Biochem. 65, 635–692 (1996).
Austin, C.A. & Marsh, K.L. Eukaryotic DNA topoisomerase IIβ. Bioessays 20, 215–226 (1998).
Jenkins, J.R. et al. Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res. 20, 5587–5592 (1992).
Lai, J.S. & Herr, W. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc. Natl Acad. Sci. USA 89, 6958–6962 (1992).
Tong, J.K., Hassig, C.A., Schnitzler, G.R., Kingston, R.E. & Schreiber, S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395, 917–921 (1998).
Zhang, Y., LeRoy, G., Seelig, H.P., Lane, W.S. & Reinberg, D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95, 279–289 (1998).
Laherty, C.D. et al. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89, 349–356 (1997).
Hassig, C.A., Fleischer, T.C., Billin, A.N., Schreiber, S.L. & Ayer, D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341–347 (1997).
Zhang, Y., Iratni, R., Erdjument-Bromage, H., Tempst, P. & Reinberg, D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89, 357–364 (1997).
Adachi, Y., Luke, M. & Laemmli, U.K. Chromosome assembly in vitro: topoisomerase II is required for condensation. Cell 64, 137–148 (1991).
Varga-Weisz, P.D. et al. Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature 388, 598–602 (1997).
Swedlow, J.R., Sedat, J.W. & Agard, D.A. Multiple chromosomal populations of topoisomerase II detected in vivo by time-lapse, three-dimensional wide-field microscopy. Cell 73, 97–108 (1993).
Cardenas, M.E., Dang, Q., Glover, C.V. & Gasser, S.M. Casein kinase II phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo. EMBO J. 11, 1785–1796 (1992).
Shapiro, P.S. et al. Extracellular signal-regulated kinase activates topoisomerase IIα through a mechanism independent of phosphorylation. Mol. Cell. Biol. 19, 3551–3560 (1999).
Shan, B. et al. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12, 5620–5631 (1992).
Taunton, J., Hassig, C.A. & Schreiber, S.L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408–411 (1996).
Sullivan, D.M., Latham, M.D., Rowe, T.C. & Ross, W.E. Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line. Biochemistry 28, 5680–5687 (1989).
Boege, F., Andersen, A., Jensen, S., Zeidler, R. & Kreipe, H. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase IIα. Delineation of a carboxy-terminal epitope with peptide antibodies. Am. J. Pathol. 146, 1302–1308 (1995).
Hochhauser, D. et al. Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIα and β in various human cancer cell lines. J. Cell. Biochem. 75, 245–257 (1999).
Kimura, K., Nozaki, N., Enomoto, T., Tanaka, M. & Kikuchi, A. Analysis of M phase-specific phosphorylation of DNA topoisomerase II. J. Biol. Chem. 271, 21439–21445 (1996).
Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475–1489 (1983).
Valkov, N.I., Gump, J.L., Engel, R. & Sullivan, D.M. Cell density-dependent VP-16 sensitivity of leukaemic cells is accompanied by the translocation of topoisomerase IIα from the nucleus to the cytoplasm. Br. J. Haematol. 108, 331–345 (2000).
Yang, W.M., Inouye, C., Zeng, Y., Bearss, D. & Seto, E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl Acad. Sci. USA 93, 12845–12850 (1996).
Yang, W.M., Yao, Y.L., Sun, J.M., Davie, J.R. & Seto, E. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J. Biol. Chem. 272, 28001–28007 (1997).
Acknowledgements
We thank I. Hickson for full-length Topo IIβ cDNA; F. Boege for monoclonal anti-Topo IIβ 3H10; Y. Zhang for anti-MTA2 antibody; R. Croxton, R. Jackson, N. Olashaw, C. Shuman, M. Thomas, K. Wright and Y. Yao for discussions and critical reading of the manuscript; and the Moffitt Cancer Center Molecular Biology and Imaging Core Facility for technical support. This work was supported by a grant from the National Institutes of Health (GM58486) to E.S.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsai, SC., Valkov, N., Yang, WM. et al. Histone deacetylase interacts directly with DNA topoisomerase II. Nat Genet 26, 349–353 (2000). https://doi.org/10.1038/81671
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/81671
This article is cited by
-
iGEM as a human iPS cell-based global epigenetic modulation detection assay provides throughput characterization of chemicals affecting DNA methylation
Scientific Reports (2023)
-
EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function
Cell Death & Disease (2021)
-
Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication
Molecular Biotechnology (2021)
-
Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain
Scientific Reports (2018)
-
Topoisomerase IIα in chromosome instability and personalized cancer therapy
Oncogene (2015)